Market Tracker

09/21 5:16pm ET

Johnson & Johnson (NYSE:JNJ)

164.21
Delayed Data
As of 5:44pm ET
 +0.40 / +0.24%
Today’s Change
133.65
Today|||52-Week Range
179.92
+4.34%
Year-to-Date
2 Outperforming Biotech Stocks to Examine on Covid-19 Vaccine Updates
11:13am / GuruFocus News - Paid Partner Content
3 Stocks You Can Keep Forever
Sep 16 / MotleyFool.com - Paid Partner Content
Fed's FOMC Meeting in Focus
11:11am / Zacks.com - Paid Partner Content
Why Johnson & Johnson (JNJ) is a Great Dividend Stock Right Now
Sep 15 / Zacks.com - Paid Partner Content
Housing Data Better than Expected on Growth in Northeast
10:47am / Zacks.com - Paid Partner Content
Is AbbVie's 4.9% Dividend Yield Safe?
Sep 15 / MotleyFool.com - Paid Partner Content
Pfizer's (PFE) COVID-19 Vaccine Successful in Children Study
10:17am / Zacks.com - Paid Partner Content
Emergent (EBS) Inks COVID-19 Manufacturing Deal With Providence
Sep 15 / Zacks.com - Paid Partner Content
3 Highly Profitable Low-Risk Stocks to Own
9:47am / GuruFocus News - Paid Partner Content
AzurRx (AZRX) Announces First Wave Bio Acquisition for $229M
Sep 14 / Zacks.com - Paid Partner Content
3 Underrated Warren Buffett Stocks That Are Smart Buys Right Now
7:25am / MotleyFool.com - Paid Partner Content
Endo (ENDP) Gains on Settlement of Opioid Cases in New York for $50M
Sep 13 / Zacks.com - Paid Partner Content
Why Protagonist Therapeutics Stock Plunged Today
Sep 20 / MotleyFool.com - Paid Partner Content
Will COVID-19 Vaccines for Children be Available by Year-End?
Sep 13 / Zacks.com - Paid Partner Content
Big Pharma Stocks Hit Hard by Drug Price Proposals
Sep 20 / GuruFocus News - Paid Partner Content
Will Pfizer's COVID Vaccine Marketing Push Pay Off?
Sep 12 / MotleyFool.com - Paid Partner Content
Pfizer Gets a Small Boost From Vaccine Trial Announcement
Sep 20 / GuruFocus News - Paid Partner Content
3 Dividend Stocks to Buy and Hold Forever
Sep 12 / MotleyFool.com - Paid Partner Content
FDA Panel Vetoes PFE/BNTX Third Jab for All, Vaccine Stocks Down
Sep 20 / Zacks.com - Paid Partner Content
3 Dividend Investing Tips That Could Earn You Thousands
Sep 11 / MotleyFool.com - Paid Partner Content
Got $1,000? Here Are 2 Unstoppable Dividend Stocks to Buy
Sep 19 / MotleyFool.com - Paid Partner Content
5 of the Safest Dividend Stocks Retirees Can Buy Right Now
Sep 11 / MotleyFool.com - Paid Partner Content
Here's Why Moderna's Stock Could Crash Before the End of 2021
Sep 19 / MotleyFool.com - Paid Partner Content
Johnson & Johnson (JNJ) Stock Moves -0.65%: What You Should Know
Sep 10 / Zacks.com - Paid Partner Content
Moderna's Bigger Catalyst: Full FDA Approval or Booster Authorization?
Sep 19 / MotleyFool.com - Paid Partner Content
Lilly's (LLY) Jardiance Gets Breakthrough Therapy Tag for HFpEF
Sep 10 / Zacks.com - Paid Partner Content
Could This News Spark a Turnaround for Ocugen?
Sep 19 / MotleyFool.com - Paid Partner Content
Decoding Mu Variant: The Next Big Threat in COVID-19 Cases?
Sep 10 / Zacks.com - Paid Partner Content
3 Popular Robinhood Stocks to Add to Your Portfolio This Month
Sep 17 / StockNews.com - Paid Partner Content
Stock Market News for Sep 10, 2021
Sep 10 / Zacks.com - Paid Partner Content
Is Moderna Winning on Vaccine Efficacy?
Sep 17 / MotleyFool.com - Paid Partner Content
Could This Be Pfizer's Next Blockbuster Vaccine?
Sep 10 / MotleyFool.com - Paid Partner Content
3 Top Warren Buffett Stocks to Buy and Hold
Sep 17 / MotleyFool.com - Paid Partner Content
Why Johnson & Johnson Is a Retiree's Dream Stock
Sep 10 / MotleyFool.com - Paid Partner Content
BlackRock Series Fund, Inc. Buys Johnson & Johnson, Qualcomm Inc, MetLife Inc, Sells Cisco ...
Sep 17 / GuruFocus News - Paid Partner Content
Could This Game-Changing FDA Approval Mean Profit for Johnson & Johnson Shareholders?
Sep 10 / MotleyFool.com - Paid Partner Content
HeartFlow: A Deep Dive
Sep 16 / MotleyFool.com - Paid Partner Content
Here's the Next Blockbuster Vaccine Opportunity for Pfizer
Sep 10 / MotleyFool.com - Paid Partner Content
Johnson & Johnson (JNJ) Stock Moves -0.12%: What You Should Know
Sep 16 / Zacks.com - Paid Partner Content
Why Shares of Johnson & Johnson Are Down 2% Today
Sep 09 / MotleyFool.com - Paid Partner Content
Why Moderna and BioNTech Topped the Market Today
Sep 16 / MotleyFool.com - Paid Partner Content
This Controversial Move Could Save Johnson & Johnson Billions
Sep 09 / MotleyFool.com - Paid Partner Content
Top Research Reports for NVIDIA, Johnson & Johnson & Toyota
Sep 16 / Zacks.com - Paid Partner Content
Moderna (MRNA) Inks Deal to Develop Ultra-Rare Disease Therapy
Sep 08 / Zacks.com - Paid Partner Content
Alzheimer's Drug for Roche Partner AC Immune Shows Promise
Sep 16 / GuruFocus News - Paid Partner Content
Global trade is in disarray. It's still booming
Aug 25 / CNN.com - Paid Partner Content
Theravance (TBPH) to Cut Workforce, Hypotension Study Fails
Sep 16 / Zacks.com - Paid Partner Content
Nasdaq hits 15,000 for first time ever. Is Dow 36,000 next?
Aug 24 / CNN.com - Paid Partner Content
Pfizer, Moderna Support COVID Vaccine Booster Before FDA Meet
Sep 16 / Zacks.com - Paid Partner Content